Prevalence of chromosomal alterations in first-trimester spontaneous pregnancy loss.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 26 05 2023
accepted: 11 10 2023
pubmed: 24 11 2023
medline: 24 11 2023
entrez: 23 11 2023
Statut: ppublish

Résumé

Pregnancy loss is often caused by chromosomal abnormalities of the conceptus. The prevalence of these abnormalities and the allocation of (ab)normal cells in embryonic and placental lineages during intrauterine development remain elusive. In this study, we analyzed 1,745 spontaneous pregnancy losses and found that roughly half (50.4%) of the products of conception (POCs) were karyotypically abnormal, with maternal and paternal age independently contributing to the increased genomic aberration rate. We applied genome haplarithmisis to a subset of 94 pregnancy losses with normal parental and POC karyotypes. Genotyping of parental DNA as well as POC extra-embryonic mesoderm and chorionic villi DNA, representing embryonic and trophoblastic tissues, enabled characterization of the genomic landscape of both lineages. Of these pregnancy losses, 35.1% had chromosomal aberrations not previously detected by karyotyping, increasing the rate of aberrations of pregnancy losses to 67.8% by extrapolation. In contrast to viable pregnancies where mosaic chromosomal abnormalities are often restricted to chorionic villi, such as confined placental mosaicism, we found a higher degree of mosaic chromosomal imbalances in extra-embryonic mesoderm rather than chorionic villi. Our results stress the importance of scrutinizing the full allelic architecture of genomic abnormalities in pregnancy loss to improve clinical management and basic research of this devastating condition.

Identifiants

pubmed: 37996709
doi: 10.1038/s41591-023-02645-5
pii: 10.1038/s41591-023-02645-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3233-3242

Subventions

Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : EU952516

Informations de copyright

© 2023. The Author(s).

Références

Quenby, S. et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet 397, 1658–1667 (2021).
pubmed: 33915094
Coomarasamy, A. et al. Sporadic miscarriage: evidence to provide effective care. Lancet 397, 1668–1674 (2021).
pubmed: 33915095
Gruhn, J. R. et al. Chromosome errors in human eggs shape natural fertility over reproductive life span. Science 365, 1466–1469 (2019).
pubmed: 31604276 pmcid: 7212007
Hassold, T. et al. Failure to recombine is a common feature of human oogenesis. Am. J. Hum. Genet. 108, 16–24 (2021).
pubmed: 33306948
Starostik, M. R., Sosina, O. A. & McCoy, R. C. Single-cell analysis of human embryos reveals diverse patterns of aneuploidy and mosaicism. Genome Res. 30, 814–825 (2020).
pubmed: 32641298 pmcid: 7370883
Vanneste, E. et al. Chromosome instability is common in human cleavage-stage embryos. Nat. Med. 15, 577–583 (2009).
pubmed: 19396175
Zamani Esteki, M. et al. Concurrent whole-genome haplotyping and copy-number profiling of single cells. Am. J. Hum. Genet. 96, 894–912 (2015).
pubmed: 25983246 pmcid: 4473724
Charalambous, C., Webster, A. & Schuh, M. Aneuploidy in mammalian oocytes and the impact of maternal ageing. Nat. Rev. Mol. Cell Biol. 24, 27–44 (2023).
pubmed: 36068367
Palmerola, K. L. et al. Replication stress impairs chromosome segregation and preimplantation development in human embryos. Cell 185, 2988–3007 (2022).
pubmed: 35858625
Zamani Esteki, M. et al. In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages. Nat. Med. 25, 1699–1705 (2019).
pubmed: 31686035
Yang, M. et al. Depletion of aneuploid cells in human embryos and gastruloids. Nat. Cell Biol. 23, 314–321 (2021).
pubmed: 33837289
Orvieto, R. et al. Do human embryos have the ability of self-correction? Reprod. Biol. Endocrinol. 18, 98 (2020).
pubmed: 33023576 pmcid: 7539487
Lebedev, I. Mosaic aneuploidy in early fetal losses. Cytogenet. Genome Res. 133, 169–183 (2011).
pubmed: 21311181
Grati, F. R. et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet. Med. 16, 620–624 (2014).
pubmed: 24525917
Byrne, A. B. et al. Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death. Nat. Med. 29, 180–189 (2023).
pubmed: 36658419 pmcid: 10333122
Nybo Andersen, A. M., Wohlfahrt, J., Christens, P., Olsen, J. & Melbye, M. Maternal age and fetal loss: population based register linkage study. BMJ 320, 1708–1712 (2000).
pubmed: 10864550
Magnus, M. C., Wilcox, A. J., Morken, N. H., Weinberg, C. R. & Haberg, S. E. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 364, l869 (2019).
pubmed: 30894356 pmcid: 6425455
Hassold, T. & Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2, 280–291 (2001).
pubmed: 11283700
Conlin, L. K. et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum. Mol. Genet. 19, 1263–1275 (2010).
pubmed: 20053666 pmcid: 3146011
Hardy, K., Hardy, P. J., Jacobs, P. A., Lewallen, K. & Hassold, T. J. Temporal changes in chromosome abnormalities in human spontaneous abortions: results of 40 years of analysis. Am. J. Med. Genet. A 170, 2671–2680 (2016).
pubmed: 27287007
Levy, B. et al. Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis. Obstet. Gynecol. 124, 202–209 (2014).
pubmed: 25004334
Zhou, Q., Wu, S. Y., Amato, K., DiAdamo, A. & Li, P. Spectrum of cytogenomic abnormalities revealed by array comparative genomic hybridization on products of conception culture failure and normal karyotype samples. J. Genet. Genomics 43, 121–131 (2016).
pubmed: 27020032
Chen, Y. et al. Characterization of chromosomal abnormalities in pregnancy losses reveals critical genes and loci for human early development. Hum. Mutat. 38, 669–677 (2017).
pubmed: 28247551 pmcid: 5671119
Li, F. X. et al. Detection of chromosomal abnormalities in spontaneous miscarriage by low‑coverage next‑generation sequencing. Mol. Med. Rep. 22, 1269–1276 (2020).
pubmed: 32626971 pmcid: 7339674
Peng, J. P. & Yuan, H. M. [Application of chromosomal microarray analysis for a cohort of 2600 Chinese patients with miscarriage]. Yi Chuan 40, 779–788 (2018).
pubmed: 30369481
Wang, Y. et al. Identification of chromosomal abnormalities in early pregnancy loss using a high-throughput ligation-dependent probe amplification-based assay. J. Mol. Diagn. 23, 38–45 (2021).
pubmed: 33069876
Finley, J. et al. The genomic basis of sporadic and recurrent pregnancy loss: a comprehensive in-depth analysis of 24,900 miscarriages. Reprod. Biomed. Online 45, 125–134 (2022).
pubmed: 35523710
Sahoo, T. et al. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges. Genet. Med. 19, 83–89 (2017).
pubmed: 27337029
Peng, G. et al. Estimation on risk of spontaneous abortions by genomic disorders from a meta-analysis of microarray results on large case series of pregnancy losses. Mol. Genet. Genomic Med. 11, e2181 (2023).
Van Prooyen Schuurman, L. et al. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: follow-up results of the TRIDENT-2 study. Am. J. Hum. Genet. 109, 1140–1152 (2022).
pubmed: 35659929 pmcid: 9247828
van der Meij, K. R. M. et al. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. Am. J. Hum. Genet. 105, 1091–1101 (2019).
pubmed: 31708118 pmcid: 6904791
Van Den Bogaert, K. et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet. Med. 23, 1137–1142 (2021).
pubmed: 33564150
Tsuiko, O. et al. Haplotyping-based preimplantation genetic testing reveals parent-of-origin specific mechanisms of aneuploidy formation. NPJ Genom. Med. 6, 81 (2021).
pubmed: 34620870 pmcid: 8497526
Capalbo, A. et al. Mosaic human preimplantation embryos and their developmental potential in a prospective, non-selection clinical trial. Am. J. Hum. Genet. 108, 2238–2247 (2021).
pubmed: 34798051 pmcid: 8715143
Ross, C. & Boroviak, T. E. Origin and function of the yolk sac in primate embryogenesis. Nat. Commun. 11, 3760 (2020).
pubmed: 32724077 pmcid: 7387521
Boss, A. L., Chamley, L. W. & James, J. L. Placental formation in early pregnancy: how is the centre of the placenta made? Hum. Reprod. Update 24, 750–760 (2018).
pubmed: 30257012
Kolte, A. M., Westergaard, D., Lidegaard, O., Brunak, S. & Nielsen, H. S. Chance of live birth: a nationwide, registry-based cohort study. Hum. Reprod. 36, 1065–1073 (2021).
pubmed: 33394013
Bortoletto, P. et al. Miscarriage syndrome: linking early pregnancy loss to obstetric and age-related disorders. EBioMedicine 81, 104134 (2022).
pubmed: 35779492 pmcid: 9244729
Shimokawa, O. et al. Array comparative genomic hybridization analysis in first-trimester spontaneous abortions with ‘normal’ karyotypes. Am. J. Med. Genet. A 140, 1931–1935 (2006).
pubmed: 16906550
Zhang, Y. X. et al. Genetic analysis of first-trimester miscarriages with a combination of cytogenetic karyotyping, microsatellite genotyping and arrayCGH. Clin. Genet. 75, 133–140 (2009).
pubmed: 19215247
Warren, J. E., Turok, D. K., Maxwell, T. M., Brothman, A. R. & Silver, R. M. Array comparative genomic hybridization for genetic evaluation of fetal loss between 10 and 20 weeks of gestation. Obstet. Gynecol. 114, 1093–1102 (2009).
pubmed: 20168112
Rajcan-Separovic, E. et al. Identification of copy number variants in miscarriages from couples with idiopathic recurrent pregnancy loss. Hum. Reprod. 25, 2913–2922 (2010).
pubmed: 20847186
Kooper, A. J., Faas, B. H., Feenstra, I., de Leeuw, N. & Smeets, D. F. Best diagnostic approach for the genetic evaluation of fetuses after intrauterine death in first, second or third trimester: QF-PCR, karyotyping and/or genome wide SNP array analysis. Mol. Cytogenet. 7, 6 (2014).
pubmed: 24428858 pmcid: 3906897
Bug, S. et al. Diagnostic utility of novel combined arrays for genome-wide simultaneous detection of aneuploidy and uniparental isodisomy in losses of pregnancy. Mol. Cytogenet. 7, 43 (2014).
pubmed: 25013457 pmcid: 4090657
Robberecht, C., Schuddinck, V., Fryns, J. P. & Vermeesch, J. R. Diagnosis of miscarriages by molecular karyotyping: benefits and pitfalls. Genet. Med. 11, 646–654 (2009).
pubmed: 19617844
Takahara, H., Ohama, K. & Fujiwara, A. Cytogenetic study in early spontaneous abortion. Hiroshima J. Med. Sci. 26, 291–296 (1977).
pubmed: 615176
Hassold, T. et al. A cytogenetic study of 1000 spontaneous abortions. Ann. Hum. Genet. 44, 151–178 (1980).
pubmed: 7316468
Kajii, T. et al. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum. Genet. 55, 87–98 (1980).
pubmed: 7450760
Byrne, J., Warburton, D., Kline, J., Blanc, W. & Stein, Z. Morphology of early fetal deaths and their chromosomal characteristics. Teratology 32, 297–315 (1985).
pubmed: 4049288
Lin, C. C., De Braekeleer, M. & Jamro, H. Cytogenetic studies in spontaneous abortion: the Calgary experience. Can. J. Genet. Cytol. 27, 565–570 (1985).
pubmed: 4063875
Dejmek, J., Vojtassak, J. & Malova, J. Cytogenetic analysis of 1508 spontaneous abortions originating from south Slovakia. Eur. J. Obstet. Gynecol. Reprod. Biol. 46, 129–136 (1992).
pubmed: 1451889
Be, C., Velasquez, P. & Youlton, R. [Spontaneous abortion: cytogenetic study of 609 cases]. Rev. Med. Chil. 125, 317–322 (1997).
pubmed: 9460269
Griffin, D. K., Millie, E. A., Redline, R. W., Hassold, T. J. & Zaragoza, M. V. Cytogenetic analysis of spontaneous abortions: comparison of techniques and assessment of the incidence of confined placental mosaicism. Am. J. Med. Genet. 72, 297–301 (1997).
pubmed: 9332658
Brajenovic-Milic, B., Petrovic, O., Krasevic, M., Ristic, S. & Kapovic, M. Chromosomal anomalies in abnormal human pregnancies. Fetal Diagn. Ther. 13, 187–191 (1998).
pubmed: 9708445
Qumsiyeh, M. B., Kim, K. R., Ahmed, M. N. & Bradford, W. Cytogenetics and mechanisms of spontaneous abortions: increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet. Cell Genet. 88, 230–235 (2000).
pubmed: 10828596
European Society of Human Reproduction and Embryology. Recurrent Pregnancy Loss Guideline of European Society of Human Reproduction and Embryology (European Society of Human Reproduction and Embryology, 2022).
Popescu, F., Jaslow, C. R. & Kutteh, W. H. Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients. Hum. Reprod. 33, 579–587 (2018).
pubmed: 29538673
Mastenbroek, S., De Wert, G. & Adashi, E. Y. The imperative of responsible innovation in reproductive medicine. N. Engl. J. Med. 385, 2096–2100 (2021).
pubmed: 34818487
Kalousek, D. K., Barrett, I. J. & Gartner, A. B. Spontaneous abortion and confined chromosomal mosaicism. Hum. Genet. 88, 642–646 (1992).
pubmed: 1551667
Lebedev, I. N., Ostroverkhova, N. V., Nikitina, T. V., Sukhanova, N. N. & Nazarenko, S. A. Features of chromosomal abnormalities in spontaneous abortion cell culture failures detected by interphase FISH analysis. Eur. J. Hum. Genet. 12, 513–520 (2004).
pubmed: 15054396
Kalousek, D. K. Pathogenesis of chromosomal mosaicism and its effect on early human development. Am. J. Med. Genet. 91, 39–45 (2000).
pubmed: 10751087
D’Ippolito, S. et al. Investigating the ‘fetal side’ in recurrent pregnancy loss: reliability of cell-free DNA testing in detecting chromosomal abnormalities of miscarriage tissue. J. Clin. Med. 12, 3898 (2023).
pubmed: 37373593 pmcid: 10298955
Gordevicius, J. et al. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing. Clin. Epigenetics 12, 153 (2020).
pubmed: 33081811 pmcid: 7574562
Che, H. et al. Noninvasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA. Genet. Med. 22, 962–973 (2020).
pubmed: 32024963
Greco, E., Minasi, M. G. & Fiorentino, F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N. Engl. J. Med. 373, 2089–2090 (2015).
pubmed: 26581010
Doubilet, P. M. et al. Diagnostic criteria for nonviable pregnancy early in the first trimester. N. Engl. J. Med. 369, 1443–1451 (2013).
pubmed: 24106937
Simoni, G. et al. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum. Genet. 63, 349–357 (1983).
pubmed: 6862440
Eiben, B. et al. Cytogenetic analysis of 750 spontaneous abortions with the direct-preparation method of chorionic villi and its implications for studying genetic causes of pregnancy wastage. Am. J. Hum. Genet. 47, 656–663 (1990).
pubmed: 2220806 pmcid: 1683793
Kuznetzova, T. V., Trofimova, I. L., Liapunov, M. S., Evdokimenko, E. V. & Baranov, V. S. Selective staining of pericentromeric heterochromatin regions in chromosomes of spontaneously dividing cells with the use of the acridine orange fluorochrome. Genetika 48, 451–456 (2012).
pubmed: 22730763
Silva, M. et al. European guidelines for constitutional cytogenomic analysis. Eur. J. Hum. Genet. 27, 1–16 (2019).
pubmed: 30275486
Ostroverkhova, N. V. et al. Detection of aneuploidy in spontaneous abortions using the comparative hybridization method. Genetika 38, 1690–1698 (2002).
pubmed: 12575456
Muller, F. et al. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol. 20, 55 (2019).
pubmed: 30871603 pmcid: 6419383
Koeck, R. M. et al. Methylome-wide analysis of IVF neonates that underwent embryo culture in different media revealed no significant differences. NPJ Genom. Med. 7, 39 (2022).
pubmed: 35768464 pmcid: 9243125
Maksimovic, J., Gordon, L. & Oshlack, A. SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol. 13, R44 (2012).
pubmed: 22703947 pmcid: 3446316
Jung, C. H. et al. sEst: accurate sex-estimation and abnormality detection in methylation microarray data. Int. J. Mol. Sci. 19, 3172 (2018).
pubmed: 30326623 pmcid: 6213967
Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13, 86 (2012).
pubmed: 22568884 pmcid: 3532182
Triche, T. J., Weisenberger, D. J., Van Den Berg, D., Laird, P. W. & Siegmund, K. D. Low-level processing of Illumina Infinium DNA methylation beadarrays. Nucleic Acids Res. 41, e90 (2013).
pubmed: 23476028 pmcid: 3627582
Aryee, M. J. et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363–1369 (2014).
pubmed: 24478339 pmcid: 4016708
Yuan, V. et al. Cell-specific characterization of the placental methylome. BMC Genomics 22, 6 (2021).
pubmed: 33407091 pmcid: 7788826

Auteurs

Rick Essers (R)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Igor N Lebedev (IN)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Ants Kurg (A)

Department of Biotechnology, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.

Elizaveta A Fonova (EA)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Servi J C Stevens (SJC)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Rebekka M Koeck (RM)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Ulrike von Rango (U)

Department of Anatomy & Embryology, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Lloyd Brandts (L)

Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.

Spyridon Panagiotis Deligiannis (SP)

Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland.

Tatyana V Nikitina (TV)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Elena A Sazhenova (EA)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Ekaterina N Tolmacheva (EN)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Anna A Kashevarova (AA)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Dmitry A Fedotov (DA)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Viktoria V Demeneva (VV)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Daria I Zhigalina (DI)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Gleb V Drozdov (GV)

Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Salwan Al-Nasiry (S)

Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
Department of Obstetrics and Gynaecology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.

Merryn V E Macville (MVE)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Arthur van den Wijngaard (A)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Jos Dreesen (J)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.

Aimee Paulussen (A)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.

Alexander Hoischen (A)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Internal Medicine, Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Expertise Center for Immunodeficiency and Autoinflammation and Radboud Center for Infectious Disease (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.

Han G Brunner (HG)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Andres Salumets (A)

Department of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia. andres.salumets@ki.se.
Competence Center on Health Technologies, Tartu, Estonia. andres.salumets@ki.se.
Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention & Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. andres.salumets@ki.se.

Masoud Zamani Esteki (M)

Department of Clinical Genetics, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands. masoud.zamaniesteki@mumc.nl.
Department of Genetics and Cell Biology, GROW-Research Institute for Oncology and Reproduction, Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands. masoud.zamaniesteki@mumc.nl.
Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention & Technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. masoud.zamaniesteki@mumc.nl.

Classifications MeSH